World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
41023
World Ranking
6546
National Ranking
3475

Adam S. Garden publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Adam S. Garden sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 786 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Adam S. Garden D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Adam S. Garden sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Adam S. Garden is affiliated with The University of Texas MD Anderson Cancer Center in the United States and has contributed extensively to medical research, particularly in the field of medicine with a focus on otorhinolaryngology, surgery, pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and oncology.

Their work covers a range of topics prominently including head and neck cancer studies, head and neck surgical oncology, advanced radiotherapy techniques, oral health in cancer treatment, lung cancer diagnosis and treatment, radiomics and machine learning in medical imaging, and salivary gland tumors diagnosis and treatment.

Frequent publication venues for their research include:

  • International Journal of Radiation Oncology*Biology*Physics
  • Radiotherapy and Oncology
  • Head & Neck
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical and Translational Radiation Oncology

They have collaborated with several frequent coauthors such as Clifton D. Fuller, G. Brandon Gunn, Jack Phan, David I. Rosenthal, and Steven J. Frank.

Selected recent papers highlight the specific areas of investigation conducted or contributed to by Adam S. Garden:

  • Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement (2020), International Journal of Radiation Oncology*Biology*Physics
  • Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results (2020), Clinical Cancer Research
  • Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses (2021), Cancer
  • Generating High-Quality Lymph Node Clinical Target Volumes for Head and Neck Cancer Radiation Therapy Using a Fully Automated Deep Learning-Based Approach (2020), International Journal of Radiation Oncology*Biology*Physics
  • Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials (2020), European Journal of Cancer

Best Publications

  • A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

    Karen K. Fu;Thomas F. Pajak;Andy Trotti;Christopher U. Jones

  • Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

    Mitchell Machtay;Jennifer Moughan;Andrew Trotti;Adam S. Garden

  • Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.

    Jerry L. Barker;Adam S. Garden;K.Kian Ang;Jennifer C. O'Daniel

  • Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

    K. Kian Ang;Qiang Zhang;David I. Rosenthal;Phuc Felix Nguyen-Tan

  • Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy.

    He Wang;Lei Dong;Jennifer O'Daniel;Radhe Mohan

  • Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

    Brian O'Sullivan;Shao Hui Huang;Jie Su;Adam S. Garden

  • Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

    Nancy Lee;Jonathan Harris;Adam S Garden;William Straube

  • Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer

    K.K Ang;A Trotti;B.W Brown;A.S Garden

  • Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.

    Lester J Peters;Helmuth Goepfert;K.Kian Ang;Robert M Byers

  • Risk, Outcomes, and Costs of Radiation-Induced Oral Mucositis Among Patients With Head-and-Neck Malignancies

    Linda S. Elting;Catherine D. Cooksley;Mark S. Chambers;Adam S. Garden

  • The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation.

    Adam S. Garden;Randal S. Weber;William H. Morrison;K.Kian Ang

  • Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma

    Carole Fakhry;Qiang Zhang;Phuc Felix Nguyen-Tan;David Rosenthal

  • Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life

    Linda S. Elting;Dorothy M. Keefe;Stephen T. Sonis;Adam S. Garden

  • Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

    Avraham Eisbruch;Jonathan Harris;Adam S. Garden;Clifford K.S. Chao

  • Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control

    Giuseppe Sanguineti;Fady B. Geara;Adam S. Garden;Susan L. Tucker

  • Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial

    Nancy Y. Lee;Qiang Zhang;David G. Pfister;John Kim

  • Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.

    Mark S. Chambers;Adam S. Garden;Merrill S. Kies;Jack W. Martin

  • Parathyroid carcinoma: A 22-year experience

    Naifa L. Busaidy;Camilo Jimenez;Mouhammed Amir Habra;Pamela N. Schultz

  • Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy

    Aaron J. Grossberg;Aaron J. Grossberg;Abdallah S. R. Mohamed;Abdallah S. R. Mohamed;Hesham Elhalawani;William C. Bennett

  • A Radiation Therapy Oncology Group (RTOG) phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas; first report of RTOG 9003

    K.K Fu;T.F Pajak;A Trotti;C.U Jones

Frequent Co-Authors

David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
William H. Morrison
William H. Morrison The University of Texas MD Anderson Cancer Center
K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
Erich M. Sturgis
Erich M. Sturgis Baylor College of Medicine
Merrill S. Kies
Merrill S. Kies The University of Texas MD Anderson Cancer Center
Bonnie S. Glisson
Bonnie S. Glisson The University of Texas MD Anderson Cancer Center
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
Tito R. Mendoza
Tito R. Mendoza The University of Texas MD Anderson Cancer Center
Paul M. Harari
Paul M. Harari University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA offers many avenues beyond a traditional MD program. Many students and professionals look to enhance their careers through flexible, online degrees that fit various backgrounds and professional goals.

For those interested in healthcare administration, consider top cahme-accredited mha programs that ensure high academic standards and robust career potential. Nurses wishing to upskill may prefer an rn to bsn with no clinicals, offering a flexible pathway to earning a Bachelor of Science in Nursing without in-person clinical requirements.

Doctor of Nursing Practice (DNP) programs can also be pursued efficiently. Explore the shortest dnp programs to expedite your journey to leadership roles. Cost-conscious learners can also find affordable dnp programs that balance quality with financial accessibility.

These online options make it possible for aspiring and current healthcare professionals to advance their expertise while balancing other commitments.

Best Scientists Citing Adam S. Garden

Trending Scientists

Recently Published Articles